Brase, Jan C <br/><br/>
ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2010 
 - 2391-401 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-09-2471  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Neoplasm--genetics<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cohort Studies<br/>Cyclophosphamide--administration & dosage<br/>DNA Topoisomerases, Type II--genetics<br/>DNA-Binding Proteins--genetics<br/>Epirubicin--administration & dosage<br/>Female<br/>Gene Amplification<br/>Humans<br/>Immunoenzyme Techniques<br/>In Situ Hybridization, Fluorescence<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Proteins--metabolism<br/>Neoplasm Staging<br/>Pilot Projects<br/>Poly-ADP-Ribose Binding Proteins<br/>RNA, Neoplasm--genetics<br/>Receptor, ErbB-2--genetics<br/>Receptors, Estrogen--metabolism<br/>Survival Rate<br/>Treatment Outcome